With expansion a prime focus for businesses worldwide, many are looking towards rapidly establishing new regions of growth, particularly in Asia, Pacific Rim countries.
ASIA by Heather Hobbs To appear in our next issue, send your Business and Financial News stories to
heather@intlabmate.com
This section of International Labmate will especially look at the success of both Asian and European companies with established premises or business partnerships, highlighting the opportunities that exist while realising potential for other companies to move into export markets.
JEOL Centre at Thailand Science Park Approved
including electron microscopes, mass spectrometers, and NMR systems already in use throughout Southeast Asia, the technical centre, based at the Thailand Science Park (TSP) and operated by the NSTDA, will be used as a base to provide technical support to governing bodies, corporations, research institutes and Japanese high tech firms in Southeast Asia and India. It will also upgrade and expand the research infrastructure in the area for local technological development.
The JEOL Asean Technical Centre is to open in the National Metal and Materials Technology Centre (above) at TSP
JEOL Ltd’s proposal to open a technical centre in Thailand was recently approved by the country's National Science and Technology Development Agency (NSTDA). Since 2004, the Thai government has stepped up efforts in developing technologies under the National Science and Technology Strategic Plan 2004-2013. With the company’s products
Exploring the emerging markets is reported to be a critical issue of JEOL's current business plan and the company has already opened local offices in China, Brazil, Russia, and India. The new technical centre was described as a strategic move in helping the victims of recent flood and developing technical support programs featuring speedy response and innovative ideas for research and development in the growing Southeastern Asian market.
A hub for industrial R&D activities, TSP can offer pilot plants, incubators, service centres, a conference & exhibition area, training facilities and space for rent. Tenants of TSP gain access to scientific and technical support such as research labs and related facilities, along with a large pool of over 600 full-time scientists, researchers and universities network. They also enjoy privileges and incentives from the Thai government.
Want more information? Circle number 227 University to Back Business and Education Development
The University of Nottingham’s many connections throughout Asia span education, research and innovation, but also business engagement, trade and investment. Established links are creating more opportunities each week. Now a new Asia Business Centre launched at the University’s Jubilee Campus will coordinate and grow this activity.
The Centre’s team will run events, support innovation partnerships and knowledge-transfer programmes across the University’s Malaysia, China and UK campuses and other offices throughout the region. It will also work with national and regional governments to create new opportunities, and manage ongoing links and relationships.
A high-level Asia Advisory Board is being created to influence and leverage engagement with Asia. Meeting on a twice yearly basis, the board will develop corporate, philanthropic, student
employment and mobility links throughout the region. The Advisory Board will aim to provide high-level influence and leverage on behalf of the University and its partners, whilst the Business Centre provides an internal and external focus for business engagement, inward investment and technology transfer opportunities.
In parallel, a new Nottingham Asia Network for academic staff will link the University’s campuses in the UK, China and Malaysia, building business, education and research collaboration.
The Nottingham Asia Network can help bring forward projects to support the Nottingham’s Impact Campaign, which aims to raise £150million over the next five years. Impact will support a series of high-impact projects on the local, national and global stage.
Want more information? Circle number 228 Dycem Opens Representative Office in Singapore
Dycem Ltd, a specialist in the reduction of cross contamination, has opened a representative office in Singapore which will be headed up by chief Asia Pacific representative Oliver Lee.
Its main function is to research the emerging markets and sectors in the region as well as extend the range of products available to the company’s established global customer base. The company offers solutions for contamination control in cleanroom environments in sectors such as pharmaceutical, data centres and electronics manufacturers, food production and healthcare environments, including hospitals.
The opening of the representative office is intended to be the
first step in engaging in the Asia Pacific market and further investment is planned for Singapore and throughout the region.
Commenting on the move, Managing Director of Dycem Ltd, Mark Dalziel, said: “This region is a largely untapped market for us; yet it is one where we know many multinationals operate and require robust solutions to maintain effective decontamination in critical production environments.
“Oliver Lee will be representing Dycem through Asia and networking to build links and contacts with businesses that can benefit commercially from improved decontamination systems and processes.”
Want more information? Circle number 229
Centre Aims to Boost Genomics Research in Malaysia
Agilent Technologies, Inc has partnered with a Malaysian University to accelerate genomics research with the establishment of the on-campus Monash-Agilent Authorised Microarray Service Centre, which will be equipped with the latest microarray instruments and provide competency training for lab professionals undertaking molecular-genetic studies of human disease.
“The establishment of the AMSC will be a timely boost in the collaboration between Agilent and Monash University Sunway campus through the Jeffrey Cheah School of Medicine and Health Sciences, providing the opportunity to access advanced technologies to strengthen our current genomics research in diabetes, cancer, neurobiology and infectious diseases,” said Professor Dato’ Dr Anuar Zaini Md Zain, Head of the School. He added that the school has forged strong collaborations with local and international academic institutions as well as leading industry players in expanding its expertise in research.
“The Monash-Agilent Authorised Microarray Service Centre, together with existing platform technologies at the school, such as liquid chromatography/mass spectrometry and proteomics, will encourage integrative and multidisciplinary research. The centre will become the platform to train next- generation scientists in genomics research and potentially spearhead new niche areas in biomedical research through support and networking with Agilent’s global customers/collaborators,” said Professor Anuar.
“We are excited about this collaboration with Monash University Sunway campus,” said Rod Minett, General Manager, Agilent Life Sciences Group, South Asia Pacific and Korea. “The knowledge gleaned from the collaboration will not only contribute toward further understanding and preventing diseases, but also cement Malaysia as a centre for life sciences research and development.”
Want more information? Circle number 230 Gyros Expands Reach in South Korea
Binex Co Ltd, a contract development and manufacturing organisation for biotechnology products in the Asia-Pacific region has purchased a Gyrolab™ workstation from Swedish microfluidic technologies specialist Gyros AB (Uppsala). S.E. Kim, President and CEO at DI Biotech, distributor of Gyros products in South Korea, said: “We are extremely pleased that Binex has become the first South Korean customer to adopt this exciting new platform. Our goal at DIBiotech is to ensure that our customers have access to the latest ground-breaking technologies. We firmly believe that the Gyros platform, will not only increase productivity, but also boost the competitiveness of South Korea’s pharma and biotech companies as well as our CROs and CMOs.”
The Gyros platform is used by major biopharmaceutical companies and their service providers during the development of biotherapeutics and vaccines to boost time-critical workflows and help meet regulatory demands. The platform also comprises control and evaluation software and microfluidic CDs in which immunoassay steps are integrated and run at nanoliter scale. Erik Walldén, CEO at Gyros, added: “We have been actively expanding our distributor network throughout the Asia-Pacific region and see this as a significant step on the way to establishing a global presence for our immunoassay platform.”
Want more information? Circle number 231
Business
Opportunities
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
